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A B S T R A C TThe evolving process of institutionalizing health technology assess-
ment (HTA) in low- and middle-income countries is not yet fully
understood. The present article aims to provide an analysis of some of
the most recent changes in the development of HTA in Brazil, as well
as the main challenges and potential barriers that may determine the
process of institutionalizing HTA in the country vis- a-vis the recent
approval of its federal HTA law at the end of 2011. Based on the
authors’ experience in HTA from an academic research perspective as
well as from national and regional/local policymaking implementa-
tions, this article also proposes some measures to foster the institu-
tionalization of HTA, for which Brazil would have to overcome three
fundamental challenges for decision making: 1) Brazil has to complete
an unfinished agenda regarding the implementation of its national
Unified Health System (SUS), 2) the complex governance of the SUSnt matter Copyright & 2012, International Society
r Inc.
.1016/j.vhri.2012.09.009
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aduate Studies in Epidemiology, Federal Universithas to be thoroughly reassessed, and 3) HTA institutionalization is to
be promoted to strengthen decision making. The recent creation of
a Brazilian national HTA body represents an important step not only
in terms of the development of HTA in the country but also regarding
the consolidation of the universal access to health care that is
guaranteed by the Brazilian Federal Constitution since the creation
of SUS in 1988. There is an urgent need to promote broader
approaches to assess the complexity of the governance of the SUS,
thus strengthening the process of HTA within the decision-making
process.
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To date, the process of institutionalization of health technology
assessment (HTA) in low- and middle-income countries though
evolving is still immature. HTA development entails different
aspects such as the existence of HTA bodies with the capacity
to identify, prioritize, and appraise new technologies as well as to
report, disseminate, and implement the resulting assessments.
Studying the development and institutionalization of HTA in
some middle-income countries, Oortwijn et al. [1] found a
substantial heterogeneity in the experiences of Argentina, Brazil,
India, Indonesia, Malaysia, Mexico, and Russia. According to the
authors, the current main efforts to institutionalize HTA in those
countries are dedicated fundamentally to instruct and train new
personnel to perform HTA, which is an important but insufficient
step. Furthermore, from the perspective of low- and middle-
income countries, the institutionalization of HTA at a national
level goes beyond training personnel and depends not only on
context-dependent factors (i.e. social, economic, political, and
cultural aspects) but also on political commitment, capacity for
investment, the development and degree of maturity of the
decision-making processes as well as the structure of thenational health care systems, among others. These are important
aspects to foster the institutionalization of HTA in every country
but are crucial determinants from the perspective of low- and
middle-income ones.
Brazil is a middle-income country that in 2011 had an
estimated population size of 192.4 million inhabitants [2]. The
country has a public-funded national health care system, the
Sistema U´nico de Sau´de (SUS). The SUS provides universal access
to all Brazilian citizens free of charge. Brazil’s economy has
experienced a relatively recent process of industrialization,
which has placed it as the sixth largest economy worldwide,
with a 2011 gross domestic product current purchasing power
parity of US $2294 [3]. The development of HTA in Brazil has been
assessed by others studies [4,5], which described its historical
antecedents and previous existing national HTA bodies [4] as well
as ‘‘an anthropological inquiry’’ into HTA and technology incorpora-
tion in Brazil [5]. The present article provides an analysis aiming to
address some of the most recent changes in the development
of HTA in Brazil, as well as the main challenges and potential
barriers that may determine the process of institutionalization of
HTA in the country vis-a-vis the recent approval of its federal HTA
law in 2011. Based on the authors’ experience in HTA as scholars asfor Pharmacoeconomics and Outcomes Research (ISPOR).
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also proposes some measures to overcome the existing challenges.
To foster the process of institutionalization of HTA, Brazil will
have to overcome three main drivers of decision making: 1) Brazil
has to finalize the implementation agenda of the SUS, 2) the
complex governance of the SUS must be reassessed given that
it represents a substantial challenge for the institutionalization
of HTA, and 3) HTA institutionalization is to be promoted to
strengthen decision making.
Brazil’s Unfinished Health Care Reform
In 1988, the Brazilian Constitution established the SUS, under
which all citizens were to be granted the right to universal care.
The Constitution states that the government must provide all the
necessary mechanisms to ensure access to health care, including
public funding to enable free access to all medicines. Since then,
Brazil has made significant advances in the process of structuring
the SUS, resulting in measurably better health conditions for its
population. These advances, coupled with the Brazilian economic
and social development observed over the last two decades, have
resulted in a substantial reduction in the burden of infectious
diseases, an increase in life expectancy, and a substantial progress
toward the Millennium Development Goals [6], which are the
pledge of the Millennium Declaration, a 189-nations’ promise to
free people from extreme poverty and deprivation until 2015.
With its large emerging economy, in recent years, Brazil has
been progressively attracting further interest from international
pharmaceutical companies and the medical device industry. The
country has become a large consumer market of medications and
other health technologies guaranteed by its Constitution.
Although the SUS represents an important social advance,
it has been clearly underfunded since its creation. With a
national health care population coverage estimated at 75%, the
SUS has been incorporating new interventions and technologies
in a context of chronic underinvestment. Brazil’s health care
expenditure per capita was estimated at US $921.00 in 2009. This
level of investment remains constant over the past 15 years [7].
The persistence of this underinvestment creates a complex
paradox. On the one hand, the Brazilian Constitution mandates
universal access to health care as a citizen’s right and a duty of
the state. That means that Brazilian citizens have free health care
at primary, secondary, and tertiary levels in a much-decentralized
health care system that shares political, legal, and financial
responsibilities within the federal, state, and municipal levels.
On the other hand, Brazil is an emerging economy with low per
capita investment in health, where the increasing demands for
new technologies contrast with a clearly underfinanced health
care system.
This paradox has contributed substantially to the process of
creation of a ‘‘judicialisation of the right to health’’ [8] whereby
thousands of lawsuits are started every year to ensure patients’
rights to high-cost medications that sometimes have unproven
and/or even debatable benefits. Previous existing national HTA
approaches and bodies were not able to have an impact on the
rising tendency of the ‘‘judicialization’’ of the right to access to
health care in Brazil. To some extent, a parallel agenda is being
created by law enforcement, increasing inequity and reducing the
availability of the already limited resources. Because of this
process of ‘‘judicialization,’’ the Brazilian Supreme Court held
a public hearing in 2009 to discuss access to health care, after
which new mechanisms for the development of HTA were
implemented. These new mechanisms resulted in December
2011 in the approval of Law 12401, which established a new
framework for HTA in Brazil and created a new national HTA
body, the Comiss ~ao Nacional de Incorporac- ~ao de Tecnologias no
Sistema U´nico de Sau´de (CONITEC)—the National Committee forIncorporation of Technologies in the SUS under the auspices of
the Brazilian MOH.
CONITEC substituted the existing previous Brazilian national
HTA body through a broader and more structured framework of
actions and responsibilities. Further, Law 12401 amended Law
8080, the main legislation of the SUS, which establishes its
principles and its related operational mechanisms of function-
ing. Law 12401 states that 1) HTA must address efficacy, effec-
tiveness, safety as well as the impact of implementing
technologies; 2) the implementation of new technologies must
be integrated with the elaboration of national clinical protocols
(i.e., critical pathways) and clinical guidelines; 3) the process of
HTA is to be centrally performed by the Brazilian MOH with
technical advice from CONITEC; 4) the rules of procedures for
HTA must also include its maximum period of duration and a
mandatory public consultation and an optional public hearing
as part of the process; 5) CONITEC is composed of 13 represen-
tatives from the following institutions: seven representatives
from the Brazilian MOH: the Science, Technology, and Strategic
Inputs Secretariat, the Executive Secretariat, the Special Secre-
tariat of Indigenous Health, the Strategic and Participatory
Management Secretariat, the Secretariat of Management of
Labor and Education in Health, and the Health Surveillance
Secretariat; one representative from the national regulatory
agency: the Brazilian Health Surveillance (Ageˆncia Nacional de
Vigilaˆncia sanita´ria); one representative from the national reg-
ulatory agency for the private health care sector (Ageˆncia
Nacional de Sau´de); one representative from the National
Association of the State Secretaries of Health; one representa-
tive from the National Association of the Municipal Secretaries
of Health; one representative from the National Health Council;
and one representative of the Federal Council of Physicians.
The diversity of CONITEC’s representatives provides a notion
of the complexity of the governance of the SUS and, therefore,
for HTA development. This topic will be further discussed
hereinafter.
Undoubtedly, the creation of CONITEC represents a substan-
tial step toward the institutionalization of HTA in Brazil and
reinforces the importance of HTA in promoting more transpar-
ency and accountability in decision-making processes. The
potential impact of CONITEC’s activities, however, ought to be
better understood within the context of the chronic underfund-
ing of the SUS and its unfinished implementation process that
is still under way to guarantee universal access to all citizens.
In Brazil, as well as in other Latin American countries, the
prerequisites for equitable access to health care are far from
being met [9]. Socioeconomic and regional inequalities are still
unacceptably large in Brazil, and thus represent a substantial
challenge to its health care agenda. Within the SUS, the persis-
tence of a large share of services that are contracted out from the
private sector results in conflicts and wider disparities [10]. In
such a context, the HTA approaches may represent important
tools helping to strengthen the decision-making process and thus
to promote equity. On the other hand, the impact of HTA
development may be largely minimized because of insufficient
economic resources and the inequalities that still remain after
almost 25 years of the creation of the SUS. As an example of
some of the existing disparities in Brazil that resulted in a
substantial unbalanced resource distribution, a recent study
performed by the MOH showed that the spending per capita on
high-cost drugs is substantially higher compared with the overall
per-capita spending on health care [11]. The absence of a national
structured strategy to educate and retain health care workers
within the SUS also represents an important obstacle to the
process of institutionalization of HTA. Few human resource
policies were implemented at a national level within the SUS
over the last 25 years.
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System
Brazil has a much-decentralized public-funded national health
care system. As stated earlier, the SUS shares political and
managerial responsibilities among the national (Brazilian MOH),
state, and municipality levels. As a federative republic, Brazil is
divided into 27 states and 5564 cities. The states and munici-
palities have administrative and legal autonomy within the SUS.
There are health councils at the national level (i.e., the National
Health Council), the state level, and in all the cities around the
country. These health councils represent permanent bodies
whose responsibilities include analyzing health plans and man-
agement reports drafted by each respective government level.
This means that, according to the governance of the SUS,
different existing bodies may have overlapping roles within the
HTA perspective. As a result, for a given health program to be
implemented, it must be evaluated and approved by the local,
state, and national health councils on a complex and perhaps
unique decision-making process that may be the most decen-
tralized worldwide. Besides the existing health councils, there are
other administrative bodies in the SUS: the Tripartite Committee
at the federal level and the bipartite committees in each of the
states. The tripartite and the 27 bipartite committees by their
turn represent intergovernmental bodies aiming to promote
negotiations and agreements at policymaking. All these existing
bodies and the respective involved stakeholders have been work-
ing to promote the processes of setting up and structuring the
multiple health care networks within the SUS. These processes
involve coordination, regulation, setting the competencies and
responsibilities, and the development of integration mechanisms
between each level of care. For example, local-level health
authorities (i.e., municipalities and state-level departments)
may legislate in health in a complementary way concerning the
national SUS legislation. Within this complex political and
administrative structure, the institutionalization of HTA may
assume two different but complementary perspectives. On the
one side, assuming that the goal of HTA is to provide policy-
makers with information on policy alternatives [12], HTA may
emerge as a potential policy tool in the processes of promoting
synergy and integration among different managerial levels and
stakeholders. On the other side, the institutionalization of HTA
shall require new and additional approaches to foster the
integration of the different existing bodies that make part of
the governance of the SUS.
These challenges also include promoting and supporting
strategies for coordination and enhancing the synergy between
the multiple stakeholders in a context of shared responsibilities
between the public and private health care sectors (see Fig. 1).SUS Governance 
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Fig. 1 – Promoting HTA coordination among multiple stakeholde
no Sistema U´nico de Sau´de; HTA, health technology assessment;Accordingly, the involvement of other existing bodies within the
SUS governance, as well as health care workers and patients’
involvement, represents initiatives that are complementary to
the mandate of CONITEC. In addition, there are several initiatives
related to HTA implementation that are not attributable to
CONITEC itself, including the development of care pathways,
health economic evaluations, as well as promoting patient
involvement and monitoring and evaluation of HTA. It remains
to be defined how these other mechanisms of integration and
governance will be implemented vis- a-vis the institutionalization
of HTA through CONITEC.
It seems that one of the biggest challenging issues for HTA
development in Brazil is to institutionalize the assessments
performed by CONITEC in the context of the complex governance
of the SUS and its related decision-making processes. In his
‘‘anthropological inquiry,’’ Gertner [5] perceived that the lack
of harmonization of HTA practices in Brazil may compromise
contextual factor considerations that are crucial for institutiona-
lizing HTA. Within this scenario, maybe a ‘‘network governance’’
approach could be a useful approach. Considering Jones et al.’s
[13] proposed definition of ‘‘network governance’’ as the involve-
ment of a ‘‘select, persistent, and structured set of autonomous’’
organizations (including the nonprofit ones) that are ‘‘engaged in
creating products or services based on implicit and open-ended
contracts to adapt the environmental contingencies and to
coordinate and safeguard exchanges,’’ these ‘‘network govern-
ance’’ approaches may be useful in this dynamic and complex
scenario where different stakeholders’ interests shall be taken
into account. Such a ‘‘network governance’’ approach may pro-
vide comprehensive mechanisms of analysis of the HTA frame-
work in a public-private health care system, as well as improve
the synergy among other existing HTA bodies.
The diversity of the contributions of the stakeholders in HTA
development is also a matter of debate after the decision of the
Brazilian MOH to centralize the evaluations of health technolo-
gies. The participation of the associations of health care workers
and the bargaining power of the rising Brazilian middle class may
also play an important role in HTA institutionalization.
Strengthening HTA to Foster the Decision-Making Process
The existing difficulties and barriers related to HTA development
in low- and middle-income countries have been demonstrated
elsewhere [14,15]. Indeed, the limited impact of economic eva-
luation in health care resource allocation has already been
documented [15]. On the other side, there is no doubt about the
relevance of conducting HTA in a particular setting where this
tool may contribute to enhance the transparency and account-
ability of the decision-making process, especially in the contextealth technology assessment 
Approval, regulatory, policy 
implementation 









rs. CONITEC, Comiss ~ao Nacional de Incorporac- ~ao de Tecnologias
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HTA also involve promoting more explicit mechanisms of priority
setting and resource allocation. Once again, it is necessary to
identify the existing decision context-related barriers in middle-
income countries. These include lack of understanding of HTA
approaches and methodologies, the rising social expectations in
health care [14], and the complexity of the governance of the
national health care systems as is the case in Brazil.
Evidence-based health policy implementation is mainly dri-
ven by processes of decision making that are centered on the
justification of the decisions where reliable scientific evidence
and the local context matter. In other words, the implementation
of evidence-based public health depends not only on the avail-
ability of reliable information but also on the existence of
mechanisms of decision making that use this information in an
effective way. Dobrow et al. [16] have conceived a conceptual
framework for evidence-based decision making focusing on how
context has an impact on what constitutes the available evidence
for making choices and for resource allocation and how that
evidence is utilized. According to the proposed framework, there
are two distinct orientations to what constitutes evidence, one
‘‘philosophical-normative’’ and the other ‘‘practical-operational’’
[16]. The first represents that available evidence has an inherent
value to justify decision making (i.e., what constitutes the validity
and reliability of a breast cancer screening strategy). The second
relies on the context dependency of the decision-making process
(i.e., despite the availability of reliable evidence toward breast
cancer screening, what are the political and economic aspects
that may influence the decision of implementing this strategy).
Assume that many others factors may contribute to a decision
outcome rather than the quality of the available evidence itself.
These two contexts represent different relationships between
evidence and context [16,17] that exert a substantial influence on
the processes of HTA development and institutionalization.
To date, few studies have analyzed the impact of HTA on
strengthening the quality of decision making. Furthermore, few
studies addressed the impact of HTA in low- and middle-income
countries.
Brazil has produced few analytical studies assessing its
decision-making processes within the SUS and its related complex
governance. For example, how do the several aforementioned
existing bodies within the governance of the SUS may improve
decision-making process? To what extent these existing bodies are
accountable? The complex governance of the SUS may represent
an obstacle to strengthening decision making? May the institutio-
nalization of HTA have a favorable impact toward more transpar-
ent and accountable decisions in the governance of the SUS? Thus,
the process of strengthening the mechanisms to foster HTA
development should include in-depth studies on how Brazilian
decision makers operate and how the HTA approaches may help
to enhance the evidence-based oriented decision making.Conclusions
In the present article, we addressed some of the main challenges
of HTA institutionalization in Brazil vis- a-vis the creation of its
new HTA national body (CONITEC) enforced by Federal Law
12401, which established a new framework for HTA in Brazil in
December 2011. The law came into force recently, after a 6-month
period of implementation. CONITEC represents the centralization
of HTA in the very decentralized governance of the SUS. Briefly,
the main challenges to the institutionalization of HTA in Brazil
include the following: The institutionalization of HTA may have its impact attenu-
ated in the context of underinvestment of the SUS over thelast 15 years as well as the still remaining inequities and
limitations to universal access to health care. Current efforts to educate health care professionals to per-
form HTA are very important, but additional initiatives to
stimulate their permanence within the SUS are crucial. The institutionalization of HTA shall require new and addi-
tional approaches to foster the integration of the different
existing bodies that make part of the complex governance of
the SUS. These include initiatives that are complementary to
CONITEC’s mandate as well as innovative network govern-
ance approaches and promoting more transparent and
accountable decision making. There is an urgent need for studies assessing the impact of
HTA on strengthening the quality of decision making in low-
and middle-income countries as a mechanism to foster
rational resource allocation. In the same way, further studies
are needed to better understand what are the main drivers,
challenges, and obstacles to implement evidence-based pol-
icymaking from a public health perspective.
Brazil has experienced remarkable progress in health over the
past two decades. These advances are related to the reorganiza-
tion of its national health system and to the changes in the
economy that promoted substantial income distribution. Com-
pleting the reform of the Brazilian national health care system
and the development of HTA agenda are inextricably linked
processes. The barriers for HTA institutionalization in Brazil
can be largely attenuated if this approach could be used to
promote transparency and accountability to the decision-
making process and thus to promote equity. Regarding that, the
creation of CONITEC represents an important step not only in
terms of the development of HTA but also regarding the con-
solidation of the health care reform and the sustainability of the
SUS. There is an urgent need to promote broader approaches
assessing the complexity of the governance of the SUS and thus
strengthening the process of HTA utilization within the decision-
making process.
As the new HTA body in Brazil, and considering the complex
governance of the SUS, CONITEC will face big challenges that
certainly go beyond its mandate. First, as it was stated before,
HTA is now centralized at CONITEC in a context of a much-
decentralized national health care system that still needs to
clarify and to define state and municipality levels of operational
responsibilities. Second, the institutionalization of HTA relies on
a broader process of policymaking within an agenda that
includes inequalities, unbalanced mechanisms of financing pri-
mary and hospital care, and substantial heterogeneity in the
provision of services in different regions across the country.
Decades of underperforming primary health care services and
a very centralized hospital-centered medicine still remain to be
reversed. In such a context, HTA will certainly contribute toward
better decision making in Brazil.
Source of financial support: No funding was received for
this study.
R E F E R E N C E S[1] Oortwijn W, Broos P, Vondeling H, et al. Mapping of health technology
assessment – development and testing of an evaluation matrix in
selected countries, poster 162, HTAi Bilbao. Gaceta Sanitaria
2012;26:244.
[2] Instituto Brasileiro de Geografia Estatı´stica. Brazil’s population
estimative in 2011. Available from: http://goo.gl/ddPGC. [Accessed
August 26, 2012].
[3] International Monetary Fund. World economic outlook database, April
2012. Available from: http://goo.gl/xm2At. [Accessed August 26, 2012].
VA L U E I N H E A LT H R E G I O N A L I S S U E S 1 ( 2 0 1 2 ) 2 5 7 – 2 6 1 261[4] Banta D, Almeida RT. The development of health technology
assessment in Brazil. Int J Technol Assess Health Care 2009;
25(Suppl. 1):255–9.
[5] Gertner A. Health technology assessment and incorporation in Brazil:
critical reflections on an emerging public-private field. J Bras Econ
Saude 2009;2:57–9.
[6] Victora CG, Barreto ML, do Carmo Leal M, et al. Health conditions and
health-policy innovations in Brazil: the way forward. Lancet
2011;377:2042–53.
[7] The Henry J. Faiser Family Foundation. U.S. global health policy: health
expenditure per capita in 2009. Available from: http://goo.gl/JuU7V.
[Accessed August 26, 2012].
[8] Biehl J, Petryna A, Gertner A, et al. Judicialisation of the right to health
in Brazil. Lancet 2009;373:2182–4.
[9] Arau´jo GTB, Caporale JE, Stefani S, et al. Is equity of access to health
care achievable in Latin America? Value Health 2011;14(Suppl):S8–12.
[10] Victora CG, Barreto ML, do Carmo Leal M, et al. Health conditions and
health-policy innovations in Brazil: the way forward. Lancet
2011;377:2042–53.[11] Brand ~ao CMR, Guerra A Jr, Cherchiglia ML, et al. Gastos do Ministe´rio
da Sau´de do Brasil com Medicamentos de Alto Custo: Uma ana´lise
centrada no paciente. Value Health 2011;14(Suppl):S71–7.
[12] Banta D. What is technology assessment? Int J Technol Assess Health
Care 2009;25(Suppl. 1):7–9.
[13] Jones C, Hesterly W, Borgatti SP. A general theory of network
governance: exchange conditions and social mechanisms. Acad Manag
Rev 1997;22:911–45.
[14] Yothasamut J, Tantivess S, Teerawattananon Y. Using economic
evaluation in policy decision-making in Asian countries: mission
impossible or mission probable? Value Health 2009;12(Suppl. 3):S26–30.
[15] Williams I, Bryan S. Understanding the limited impact of economic
evaluation in health care resource allocation: a conceptual framework.
Health Policy 2007;80:135–43.
[16] Dobrow MJ, Goel V, Upshur RE. Evidence-based health policy: context
and utilisation. Soc Sci Med 2004;58:207–17.
[17] Dobrow MJ, Goel V, Lemieux-Charles L, Black NA. The impact of context
on evidence utilization: a framework for expert groups developing
health policy recommendations. Soc Sci Med 2006;63:1811–24.
